Capital Impact Advisors’s Pediatrix Medical MD Stock Holding History

Capital Impact Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-47,580	Closed	-$676K	–	147
2023 Q2	$676K	Buy	47,580 +6,952	+17%	+$97.6K	0.74%	49
2023 Q1	$606K	Buy	40,628 +2,393	+6%	+$36.3K	0.74%	45
2022 Q4	$568K	Buy	38,235 +1,337	+4%	+$21.8K	0.56%	65
2022 Q3	$575K	Buy	36,898 +500	+1%	+$10.1K	0.57%	59
2022 Q2	$765K	Buy	36,398 +2,590	+8%	+$52.9K	0.71%	31
2022 Q1	$794K	Buy	+33,808	New	+$828K	0.58%	68
2018 Q1	–	Sell	-19,024	Closed	-$1.02M	–	142
2017 Q4	$1.02M	Hold	19,024	–	–	0.44%	125
2017 Q3	$820K	Sell	19,024 -5,969	-24%	-$284K	0.37%	139
2017 Q2	$1.51M	Hold	24,993	–	–	0.69%	46
2017 Q1	$1.73M	Buy	+24,993	New	+$1.74M	0.69%	52

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Impact Advisors's MD Position: Q3 2023 in Review

Capital Impact Advisors sold out of Pediatrix Medical (MD) in Q3 2023, closing a stake of 47,580 shares — an estimated $676K sold.

Capital Impact Advisors first reported a position in MD in Q1 2017 and held it in 10 quarters. The position peaked at $1.73M in Q1 2017. 205 funds tracked by Wall St. Rank hold MD as of Q3 2023.

Capital Impact Advisors reported no remaining Pediatrix Medical position as of Q3 2023 after selling out during the quarter.
Capital Impact Advisors sold 47,580 Pediatrix Medical shares in Q3 2023, an estimated $676K.
Capital Impact Advisors first reported a position in Pediatrix Medical in Q1 2017 and held it in 10 quarters.
Capital Impact Advisors's Pediatrix Medical position peaked at $1.73M in Q1 2017.
205 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2023.

Based on Capital Impact Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.